Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So, with your stellar record of being WRONG, that would narrow it down to Biogen as our suitor.
The video does seem to fit your profile. Nothing wrong with that. But there is too much evidence to the contrary to support your claim that this is a dud. Missling does seem to lose his way in bringing blacamesine forward but that doesn’t speak to the evidence. Time will tell. Dance on.
The Best to you, also. I am glad things are working out for you. I will be taking my chances here for a while longer. As an early investor here, I am still in the green but no longer expecting generational wealth here. Best of Luck.
You talking about Ninsense George? Just asking.
Including amyloid plaque reduction as a significant part of the results seems a first for A273. Maybe their in-house former FDA folks see it as a way to let the FDA off the hook somewhat and get us a seat at the FDA table by including Anavex in the amyloid plaque reduction crowd.
Glad I added today...only 3303 at average $7.78/share but that took care of my jitters that this is about to take off.
That was just another classic Pump by fly on the wall Pump and Dump George. It didn't work today. Expect more of the same for Dump wannabe George.
Who told you that, fly on the wall pumper dumper george?
Pumping and dumping George and brad seem to be the same idiot.
I haven’t been here for several days. Thanks for reminding me why I haven’t missed it. Carry on children.
I wish you the best, sab. A family member's inlaw had blood cancer. He was treated with Rituxan. The results were so amazing, the doctors wanted to use him for a study. Let's hope the same results are in store for you. I will pray for you at 3 PM today.
Maybe this recent post will help clarify things a bit:
Pump and Dumps
A "pump and dump" scheme involves a player accumulating a stock position and then issuing unrealistically optimistic comments about the company to attract buyers who will further bid up the price. The player then sells into the rising stock price to make a profit. Pump and dump schemes are typically implemented on small or microcap stocks, where there is a better chance of impacting the price of the stock with false news and a better chance of attracting retail investors who are more susceptible to that message.
She has been here for a while and has a p&d history dating back many years. Maybe she is looking for redemption now, idk.
Any Day Now!
Thanks for this earlier post TempePhil:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170667181
Aka p&d George, IMO
Like 99.9% of your posts. Looks like your endless p&d activity isn't working as well as it did around 2016.
Just waiting for your signature "Good Luck and God Bless" before putting you on ignore.
Hey, golly gee. Thank you very much for schooling me in the typical processes in biotechnology. Having worked in the industry for well over two decades, I’m sure I still have a lot to learn.
Blaiming outside forces for the sorry lack of movement toward bringing our product to market is to deny the obvious. Dr Missling has demonstrated outstanding scientific ability but has failed miserably in the role of ceo to bring our product to market. Anyone believing otherwise is, as you would say, woefully naïve.
Listening to the advertisements for cancer drugs and their side effects and the brain swelling/bleeding side effects of the AD drugs and the vomiting/diarrhea side effects of relatively ineffective Rett Syndrome drugs coming on the market, the efforts of the FDA seem more geared toward population control than health care. Missling almost seems part of this wretched game. Sorry. In my younger days, there were times when I had to adjust my demeanor to achieve an objective. WTF. Why does Missling come across as someone that lacks that ability? Time has long since passed to either Lead, Follow or Get Out of the Way. Do something.
Why no bid/ask share price on yahoo. Seems unusual/manipulative?
Very, very unlikely today, IMO. Fasten your seatbelt. We have just now moved to the launch pad.
Word is.getting out that their new drug is an Aduhelm clone. Idk but does anyone have a rational answer why we are not seeking approval for our drug anywhere in the world? If Missling won't do it, why not. Just asking.
Have you ever, ever been dumping this stock while pumping?
“ANAVEX®2-73 (blarcamesine) has previously received Fast Track designation, Rare Pediatric Disease designation and Orphan Drug designation from the FDA for the treatment of Rett syndrome.”
There seems to be a mismatch with the Fast Track Drug designation and the plans our ceo has in response to our stellar results. Is he serious? Missling always talks about being very excited with the results we are getting. Really? “Anavex plans to submit the data for publication in a peer-reviewed medical journal.” Doesn’t sound very exciting. Sounds more and more like a ceo looking for an opportunity to exit left. Just my opinion.
It is becoming increasingly apparent to me that if we ever bring a product to market, Missling will not be our ceo. He is in pretty good stead and will be more so after exercising options. If he is ever forced out as ceo, he will leave a wealthy man. The part of this mornings Rett announcement that caused discomfort was his looking for a journal entry instead of approaching the FDA with these stellar results. All my opinion.
Whoever posted with erronious date needs to be fired, Now!
Is there a biomarker to help determine the best dose to achieve an individual's required baseline? If not, a periodic blood test will be needed to figure it out. Hopefully, the company has smarter people than me to figure it out. This whole Anavex thing has been a real brain teaser, especially in comparison to the other bios bringing their junk to market with the FDA approvals. We need to get our sht together and present it to the FDA. It's either WGT or we DON'T. It's becoming a coin toss for me on some days. I did load up last Thurs or Fri for almost 2600 more shares at $8.20. GLTA.
Someone dumped 66K shares at 9:30 at the 10 cent pop.
Good point. It would seem so. Hopefully, that senerio happens. I try not to put the cart before the horse as many here seem to be doing with this announcement.
I wonder if 2-73 could work for your 'real -credible -unspun sign of belief.' My RCUSOB will only be activated by NDA submission and subsequent FDA approval.
Not saying it was a bad thing. It seems Anavex sought government approval to continue to legally provide 2-73 to trial participants, post-trial. That certainly seems a necessary step to legally do that. I don't read that 2-73 is now available to all Rett Syndrom sufferers without regard to trial participation, unfortunately.
Nothing really new here. All of our clinical trials allow extended use for trial participents. Only for trial participents. Doesn't seem very compassionate to me. All fluff.
Setting us up for a buyout is the only way that somewhat explains our ceo’s missteps over the years. If that is the direction he has been taking us then I must say he is pretty good at it. Releasing several upcoming data sets in close proximity to each other will certainly bring us some attention.